Price $4.17 |
Market Cap
113.3M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
-
|
P/S
1.58
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
45.5
|
Op. Cash Flow
7.3K
|
FCF
0.0
|
|
Op. Margin
12.00%
|
Net Margin
4.10%
|
ROE
-3.50%
|
ROI
39.00%
|
|
ROA
3.40%
|
EPS Growth
103.60%
|
Current Ratio
3.0
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Capital Senior Living Corporat (CSU) | $31.46 | - | - | 78.9M | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $60.33 | - | 3.00% | 146.93B | Strong Buy |
| Endo International PLC (ENDP) | $2.76 | - | - | 499.7M | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.59 | - | - | 30.3M | Strong Buy |
| Cidara Therapeutics Inc (CDTX) | $2.14 | - | - | 107.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
